<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Wowchemy 4.8.0 for Hugo"><meta name=description content="Masitinib is currently the only tyrosine kinase inhibitor in late-stage development for ALS. Masitinib distinguishes itself from other ALS developmental drugs by exerting neuroprotection in both central and peripheral nervous systems."><link rel=alternate hreflang=en-us href=/alternative-treatment/masitinib/><link rel=preconnect href=https://fonts.gstatic.com crossorigin><meta name=theme-color content="#2962ff"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css integrity="sha256-FMvZuGapsJLjouA6k7Eo2lusoAX9i0ShlWFG6qt7SLc=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/styles/github.min.css crossorigin=anonymous title=hl-light><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/styles/dracula.min.css crossorigin=anonymous title=hl-dark disabled><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.css integrity="sha512-1xoFisiGdy9nvho8EgXuXvnpR5GAMSjFwp40gSRE3NwdUdIMIKuPa7bqoUhLD0O/5tPNhteAsE5XyyMi5reQVA==" crossorigin=anonymous><script src=https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.2.2/lazysizes.min.js integrity="sha512-TmDwFLhg3UA4ZG0Eb4MIyT1O1Mb+Oww5kFG0uHqXsdbyZz9DcvYQhKpGgNkamAI6h2lGGZq2X8ftOJvF/XjTUg==" crossorigin=anonymous async></script><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap"><link rel=stylesheet href=/css/wowchemy.css><script async src="https://www.googletagmanager.com/gtag/js?id=UA-79609500-2"></script><script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments);}
function trackOutboundLink(url,target){gtag('event','click',{'event_category':'outbound','event_label':url,'transport_type':'beacon','event_callback':function(){if(target!=='_blank'){document.location=url;}}});console.debug("Outbound link clicked: "+url);}
function onClickCallback(event){if((event.target.tagName!=='A')||(event.target.host===window.location.host)){return;}
trackOutboundLink(event.target,event.target.getAttribute('target'));}
gtag('js',new Date());gtag('config','UA-79609500-2',{});document.addEventListener('click',onClickCallback,false);</script><link rel=manifest href=/index.webmanifest><link rel=icon type=image/png href=/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_32x32_fill_lanczos_center_2.png><link rel=apple-touch-icon type=image/png href=/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_192x192_fill_lanczos_center_2.png><link rel=canonical href=/alternative-treatment/masitinib/><meta property="twitter:card" content="summary_large_image"><meta property="og:site_name" content="ALS | MND"><meta property="og:url" content="/alternative-treatment/masitinib/"><meta property="og:title" content="Masitinib | ALS | MND"><meta property="og:description" content="Masitinib is currently the only tyrosine kinase inhibitor in late-stage development for ALS. Masitinib distinguishes itself from other ALS developmental drugs by exerting neuroprotection in both central and peripheral nervous systems."><meta property="og:image" content="/alternative-treatment/masitinib/featured.png"><meta property="twitter:image" content="/alternative-treatment/masitinib/featured.png"><meta property="og:locale" content="en-us"><meta property="article:published_time" content="2021-02-17T00:00:00+00:00"><meta property="article:modified_time" content="2021-02-20T12:28:08+13:00"><title>Masitinib | ALS | MND</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents><script>window.wcDarkLightEnabled=true;</script><script>const isSiteThemeDark=false;</script><script src=/js/load-theme.js></script><aside class=search-results id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=#><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=/>ALS | MND</a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=/>ALS | MND</a></div><div class="navbar-collapse main-menu-item collapse justify-content-start" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=/what_is_it/><span>What is it?</span></a></li><li class=nav-item><a class=nav-link href=/just-got-diagnosed/><span>Just Got Diagnosed?</span></a></li><li class=nav-item><a class=nav-link href=/mimickers/><span>Mimickers</span></a></li><li class=nav-item><a class=nav-link href=/alternative-treatments/><span>Alternative Treatments</span></a></li><li class=nav-item><a class=nav-link href=/stories/><span>Stories</span></a></li><li class=nav-item><a class=nav-link href=/support/><span><strong>Support near you</strong></span></a></li><li class=nav-item><a class=nav-link href=/contact/><span>Contact</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=# aria-label=Search><i class="fas fa-search" aria-hidden=true></i></a></li><li class="nav-item dropdown theme-dropdown"><a href=# class=nav-link data-toggle=dropdown aria-haspopup=true><i class="fas fa-moon" aria-hidden=true></i></a><div class=dropdown-menu><a href=# class="dropdown-item js-set-theme-light"><span>Light</span></a>
<a href=# class="dropdown-item js-set-theme-dark"><span>Dark</span></a>
<a href=# class="dropdown-item js-set-theme-auto"><span>Automatic</span></a></div></li></ul></div></nav><article class=article><div class="article-container pt-3"><h1>Masitinib</h1><div class=article-metadata><span class=article-date>Last updated on
Feb 20, 2021</span></div></div><div class="article-header article-container featured-image-wrapper mt-4 mb-4" style=max-width:720px;max-height:410px><div style=position:relative><img src=/alternative-treatment/masitinib/featured_hu631ea52e815b7c5e35fc30eacbd8db89_58011_720x0_resize_lanczos_2.png alt class=featured-image></div></div><div class=article-container><div class=article-style><h2 id=science>Science</h2><p>Masitinib is an oral treatment designed to block the activity of multiple cell types — including macrophages, neutrophils, mast cells, and Schwann cells — involved in the inflammatory and neurodegenerative processes marking ALS. It does so through the activity of proteins called tyrosine kinases.<sup id=fnref:1><a href=#fn:1 class=footnote-ref role=doc-noteref>1</a></sup></p><p>Check <a href=https://www.ab-science.com/science/masitinib-in-neurodegenerative-disorders/ target=_blank rel=noopener>AB Science</a> page to know more.</p><h2 id=articles>Articles</h2><div class="alert alert-note"><div>The titles of the articles are clickable and will redirect you to the online resource.
The quote is the conclusion or an extract of the article.
Please be sure to read them fully</div></div><h4 id=2019---add-on-masitinib-slows-progression-of-als-final-phase-23-trial-results-showhttpswwwtandfonlinecomdoifull1010802167842120191632346><a href=https://www.tandfonline.com/doi/full/10.1080/21678421.2019.1632346 target=_blank rel=noopener>2019 - Add-on Masitinib Slows Progression of ALS, Final Phase 2/3 Trial Results Show</a></h4><p><a class="btn btn-outline-primary" target=_blank rel="noopener noreferrer" href=./masitinib_as_an_add_on_therapy_to_riluzole_in_patients_with_als.pdf>Download PDF</a></p><blockquote><p>Masitinib in combination with Rilutek (riluzole) slows functional decline of patients with amyotrophic lateral sclerosis (ALS) who have a typical disease progression, according to the final report of AB Science‘s Phase 2/3 clinical trial.</p><p>At 11 months of treatment with the combo, the rate of disability progression was reduced by 27%, as compared to a placebo plus Rilutek. In contrast, patients who have a faster disease worsening do not benefit as much from adding masitinib to their treatment.</p></blockquote><p><img src=./masitinib_phaseII.png alt="PhaseII results"></p><section class=footnotes role=doc-endnotes><hr><ol><li id=fn:1 role=doc-endnote><p>from <a href=https://alsnewstoday.com/news-posts/2020/04/03/fda-clears-ab-science-to-open-phase-3-trial-of-masitinib-add-on-als-treatment/ target=_blank rel=noopener>ALS News Today</a> <a href=#fnref:1 class=footnote-backref role=doc-backlink>&#8617;&#xfe0e;</a></p></li></ol></section></div><div class=article-tags><a class="badge badge-light" href=/tag/drugs/>drugs</a></div><div class=share-box aria-hidden=true><ul class=share><li><a href="https://twitter.com/intent/tweet?url=/alternative-treatment/masitinib/&text=Masitinib" target=_blank rel=noopener class=share-btn-twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=/alternative-treatment/masitinib/&t=Masitinib" target=_blank rel=noopener class=share-btn-facebook><i class="fab fa-facebook"></i></a></li><li><a href="mailto:?subject=Masitinib&body=/alternative-treatment/masitinib/" target=_blank rel=noopener class=share-btn-email><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=/alternative-treatment/masitinib/&title=Masitinib" target=_blank rel=noopener class=share-btn-linkedin><i class="fab fa-linkedin-in"></i></a></li><li><a href="whatsapp://send?text=Masitinib%20/alternative-treatment/masitinib/" target=_blank rel=noopener class=share-btn-whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=/alternative-treatment/masitinib/&title=Masitinib" target=_blank rel=noopener class=share-btn-weibo><i class="fab fa-weibo"></i></a></li></ul></div></div></article><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/instant.page/5.1.0/instantpage.min.js integrity="sha512-1+qUtKoh9XZW7j+6LhRMAyOrgSQKenQ4mluTR+cvxXjP1Z54RxZuzstR/H9kgPXQsVB8IW7DMDFUJpzLjvhGSQ==" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/highlight.min.js integrity="sha512-TDKKr+IvoqZnPzc3l35hdjpHD0m+b2EC2SrLEgKDRWpxf2rFCxemkgvJ5kfU48ip+Y+m2XVKyOCD85ybtlZDmw==" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/languages/r.min.js></script><script src=https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.js integrity="sha512-SeiQaaDh73yrb56sTW/RgVdi/mMqNeM2oBwubFHagc5BkixSpP1fvqF47mKzPGWYSSy4RwbBunrJBQ4Co8fRWA==" crossorigin=anonymous></script><script>const code_highlighting=true;</script><script>const search_config={"indexURI":"/index.json","minLength":1,"threshold":0.3};const i18n={"no_results":"No results found","placeholder":"Search...","results":"results found"};const content_type={'post':"Posts",'project':"Projects",'publication':"Publications",'talk':"Talks",'slides':"Slides"};</script><script id=search-hit-fuse-template type=text/x-template>
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script><script src=https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin=anonymous></script><script src=/js/wowchemy.min.4c2bca31150ce93c5a5e43b8a50f22fd.js></script><div class=bottom-panel id=bottom-panel><div class=popup-wrapper id=popup-wrapper></div></div><script src=/js/hugo-footnotes-popup/footnotes.js></script><div class=container><footer class=site-footer><p class=powered-by></p><p class=powered-by>Published with
<a href=https://wowchemy.com target=_blank rel=noopener>Wowchemy</a> —
the free, <a href=https://github.com/wowchemy/wowchemy-hugo-modules target=_blank rel=noopener>open source</a> website builder that empowers creators.
<span class=float-right aria-hidden=true><a href=# class=back-to-top><span class=button_icon><i class="fas fa-chevron-up fa-2x"></i></span></a></span></p></footer></div><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code class="tex hljs"></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i>Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i>Download</a><div id=modal-error></div></div></div></div></div></body></html>